The utility of smartphone-based, ecological momentary assessment for depressive symptoms.
Samantha J Yim,Leanna M W Lui,Yena Lee,Joshua D Rosenblat,Renee-Marie Ragguett,Caroline Park,Mehala Subramaniapillai,Bing Cao,Aileen Zhou,Carola Rong,Kangguang Lin,Roger C Ho,Alexandria S Coles,Amna Majeed,Elizabeth R Wong,Lee Phan,Flora Nasri,Roger S McIntyre
DOI: https://doi.org/10.1016/j.jad.2020.05.116
IF: 6.533
2020-01-01
Journal of Affective Disorders
Abstract:BACKGROUND:Major Depressive Disorder (MDD) is a common and debilitating mood disorder. Individuals with MDD are often misdiagnosed or diagnosed in an untimely manner, exacerbating existing functional impairments. Ecological momentary assessment (EMA) involves the repeated sampling of an individual's symptoms within their natural environment and has been demonstrated to assist in illness assessment and characterization. Capturing data in this way would set the stage for improved treatment outcomes and serve as a complementary resource in the management and treatment of depressive symptoms.
METHODS:Online databases PubMed/MedLine and PsycINFO were searched using PRISMA guidelines and combinations of the following keywords: EMA, depression, smartphone app, diagnosing, symptoms, phone, app, ecological momentary assessment, momentary assessment, data mining, unobtrusive, passive data, GPS, sensor.
RESULTS:A total of nineteen original articles were identified using our search parameters and ten articles met the inclusion criteria for full-text review. Among the ten relevant studies, three studies evaluated feasibility, seven evaluated detection, and three evaluated treatment of MDD.
LIMITATIONS:Limitations include that the design of all of the studies included in this review are non-randomized. It should be noted that most of the studies included were pilot studies and/or exploratory trials lacking a control group.
CONCLUSIONS:Available evidence suggests that the use of passive smartphone-based applications may lead to improved management of depressive symptoms. This review aids the creation of new EMA applications, highlights the potential of EMA usage in clinical settings and drug development, emphasizes the importance for regulation of applications in the mental health field, and provides insight into future directions.